De Block CEM, Drinck E, Verhaegen A, van Gaal LF (2022) Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
To elucidate the transcriptional program associated with GLA-mutant kidney organoids and the consequences, 100 differentially expressed genes (DEGs) were first identified on the basis of fold change values (50 genes were upregulated and downregulated in GLA-mutant Fabry kidney organoids compared with WT kidney organoids
No UK, EU, or US approval has been granted
We have no data on what that would do to a newborn infant if these (drugs) are transmitted through breast milk
Prioritize protein and fiber to support satiety
We want to hear if anything changes, for the better or worse